News for Nova Mentis Life Science Corp. (NMLSF)

December 6, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to watc...

COMPASS Pathways is a mental healthcare company that specializes in psilocybin therapy. Read more to see my thoughts on CMPS stock and why it is a Hold.

Share this article VANCOUVER – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology company and global leader in first-in-c...

Wellbeing Digital Sciences Inc. , an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and... | April 18, 2023

VANCOUVER, British Columbia — Wellbeing Digital Sciences Inc. (“

VANCOUVER, British Columbia — Wellbeing Digital Sciences Inc. (“

Wellbeing Digital (OTC: KONEF) subsidiary KGK Sciences will advance with the first-ever Phase 2a clinical trial assessing repetitive, oral microdose psilocybin therapy for Fragile X Syndrome (FXS), a genetic disorder.

A section 56 exemption can enable an approved medical professional to prescribe select controlled substances without legal consequence, in order to better treat people with otherwise... | February 14, 2023

The partnership leading the way on psilocybin therapy for Fragile X Syndrome (FXS), the major genetic cause of Autism Spectrum Disorder (ASD), has received approval from Health Canada in the form of a No Objection letter and is set to proceed with the first-ever Phase 2a clinical trial on the magic mushrooms therapy for this condition.

Share this article VANCOUVER – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology company and global leader in first-in-c...

Vancouver, British Columbia - December 8, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLS...

TORONTO - May 9, 2022 (Investorideas.com Newswire) dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce the a...

The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada